The Cardiac-Diabetes Nexus: How Heart Failure Influences New-Onset Disease
A new study investigates the complex relationship between heart failure events and the subsequent development of new-onset diabetes in patients with heart failure and mildly reduced or preserved ejection fraction. The research also examines the potential role of the medication finerenone in this interplay. This analysis is crucial for understanding the bidirectional risks between cardiovascular and metabolic conditions, which are common comorbidities in perioperative and critical care populations.
Why it might matter to you: For anesthesiologists managing perioperative care, this research underscores the importance of comprehensive cardiovascular and metabolic risk assessment. Patients with heart failure, especially those with preserved ejection fraction, represent a significant portion of the surgical population and are at heightened risk for hemodynamic instability. Understanding the link to new-onset diabetes can inform preoperative optimization, intraoperative monitoring strategies, and long-term postoperative management plans to improve patient outcomes.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
